Functional and metabolic evaluation of the hypertrophied heart using MRI and 31P-MRS

Magnetic Resonance Materials in Physics, Biology, and Medicine

Volumn 6, Issue 2-3, 1998, Pages 168-170

  Lamb, Hildo J ^a   Van Der Laarse, A ^a   Pluim, B M ^a   Beyerbacht, H P ^a   Doornbos, J ^a   Van Der Wall, E E ^a   De Roos, A ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

31P MRS; Left ventricular hypertrophy; MRI

Indexed keywords

AORTA VALVE DISEASE; ATHLETE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONFERENCE PAPER; HEART FUNCTION; HEART HYPERTROPHY; HEART MUSCLE METABOLISM; HEART SCINTISCANNING; HUMAN; HYPERTENSION; IMAGE ANALYSIS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL;

ADENOSINE TRIPHOSPHATE; AORTIC VALVE INSUFFICIENCY; AORTIC VALVE STENOSIS; DIASTOLE; HEART; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MAGNETIC RESONANCE IMAGING; MALE; MYOCARDIUM; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PHOSPHOCREATINE; PHOSPHORUS; PHYSICAL FITNESS; SYSTOLE; VENTRICULAR FUNCTION, LEFT;

EID: 0032168714     PISSN: 13528661     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1352-8661(98)00055-6     Document Type: Conference Paper

References (17)

1. Levy D, Garrison RJ, Savage DD, Kanel WB, Castelli WP Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 322:1990;1561-1566.
2. Sadoshima J, Xu Y, Slayter HS, Izumo S Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell. 75:1993;977-984.
3. van Heugten HAA, de Jonge HW, Bezstarosti K, Sharma HS, Verdouw PD, Lamers JMJ Intracellular signaling and genetic reprogramming during agonist-induced hypertrophy of cardiomyocytes. Ann N Y Acad Sci. 752:1995;343-352.
4. Fouad FM, Tarazi RC, Gallagher JH, Macintyre WJ, Cook SA Abnormal left ventricular relaxation in hypertensive patients. Clin Sci. 59:1980;411s-414s.
5. Smith V, Schulman P, Karimeddini MK, White WB, Meeran MK, Katz AM Rapid ventricular filling in left ventricular hypertrophy: II. Pathologic hypertrophy. J Am Coll Cardiol. 5:1985;869-874.
6. Osbakken M, Douglas PS, Ivanics T, Zhang D, Van Winkle T Creatine kinase kinetics studied by phosphorus-31 nuclear magnetic resonance in a canine model of chronic hypertension-induced cardiac hypertrophy. J Am Coll Cardiol. 19:1992;223-228.
7. Zhang J, Merkle H, Hendrich K et al. Bioenergetic abnormalities associated with severe left ventricular hypertrophy. J Clin Invest. 92:1993;993-1003.
8. Hartiala JJ, Mostbeck GH, Foster E et al. Velocity-encoded cine MRI in the evaluation of left ventricular diastolic function: measurement of mitral valve and pulmonary vein flow velocities and flow volume across the mitral valve. Am Heart J. 125:1993;1054-1066.
9. Pattynama PMT, Lamb HJ, van der Velde EA, van der Wall EE, de Roos A Left ventricular measurements with cine and spin-echo MR imaging: A study of reproducibility with variance component analysis. Radiology. 187:1993;261-268.
10. Weiss RG, Bottomley PA, Hardy CJ, Gerstenblith G Regional myocardial metabolism of high-energy phosphates during isometric exercise in patients with coronary artery disease. N Engl J Med. 323:1990;1593-1600.
11. 31P-NMR spectroscopy. NMR Biomed. 9:1996;217-227.
12. Neubauer S, Horn M, Cramer M et al. Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy. Circulation. 96:1997;2190-2196.
13. Joint national committee on detection, evaluation, and treatment of high blood pressure. The fifth report of the joint national committee on detection, evaluation, and treatment of high blood pressure (JNC V). Arch Intern Med 1993;153:154-183.
14. Pluim BM, Lamb HJ, Kayser HWM et al. Functional and metabolic evaluation of the athlete's heart by magnetic resonance imaging and dobutamine stress magnetic resonance spectroscopy. Circulation. 97:1998;666-672.
15. Lamb HJ, Doornbos J, van der Velde EA, Kruit MC, Reiber JHC, de Roos A Echo planar MRI of the heart on a standard system: validation of measurements of left ventricular function and mass. J Comput Assist Tomogr. 20:1996;942-949.
16. 31P-MRS. Circulation. 96:1997;2969-2977.
17. Susic D, Nuñez E, Frohlich ED, Prakash O Angiotensin II increases left ventricular mass without affecting myosin isoform mRNAs. Hypertension. 28:1996;265-268.